TY - JOUR
T1 - Long-term surgical results in sudden death syndrome associated with cardiac dysfunction after myocardial infarction
AU - Bolooki, H.
AU - Horowitz, M. D.
AU - Interian, A.
AU - Thurer, R. J.
AU - Palatianos, G. M.
AU - DeMarchena, E. J.
AU - Perryman, R. A.
AU - Myerburg, R. J.
AU - Kron, I. L.
AU - Harken, A. H.
AU - Cox, J. L.
AU - Lawrie, G. M.
PY - 1992
Y1 - 1992
N2 - To evaluate the surgical results in patients with inducible ventricular tachyarrhythmias due to coronary disease and left ventricular dysfunction, the authors reviewed their experience in 170 patients who had survived one or more cardiac arrests after myocardial infarction and were unresponsive to drug therapy based on electrophysiologic studies (EPS). There were nine operative deaths (5%). Based on intraoperative EPS, surgical remodeling of left ventricular dysfunction (aneurysm resection, infarct debulking, and septal reinforcement) with map-guided cryoablation and coronary artery bypass graft was performed in 34 patients (group A), and left ventricular remodeling and coronary artery bypass graft without guided endocardial resection was performed in 25 patients (group B). Forty-three patients (group C) had coronary artery bypass graft with implantation of an automatic implantable cardioverter defibrillator (AICD). Group D (68 patients) received AICD only. After operation, based on EPS results, four patients in group A (12%) and three patients in Group B (15%) required AICD implantation. Overall survival at 6 years was 65%, 48%, 85%, and 58% in patient groups A, B, C, and D, respectively (p = not significant). During follow-up in group A patients, none died suddenly and none needed AICD. In group B, two patients required AICD 3 and 5 years later, and five patients died suddenly. The incidence of sudden death was 2.3%/patient/year and 3.5%/patient/year after AICD implantation (groups C and D). At 6 years, cardiac-event-free survival was 80% and 70% for groups A and B and 38% and 24% for groups C and D, respectively (p < 0.001). Patients receiving map-guided ablative procedures had significantly improved cardiac-event-free survival rates.
AB - To evaluate the surgical results in patients with inducible ventricular tachyarrhythmias due to coronary disease and left ventricular dysfunction, the authors reviewed their experience in 170 patients who had survived one or more cardiac arrests after myocardial infarction and were unresponsive to drug therapy based on electrophysiologic studies (EPS). There were nine operative deaths (5%). Based on intraoperative EPS, surgical remodeling of left ventricular dysfunction (aneurysm resection, infarct debulking, and septal reinforcement) with map-guided cryoablation and coronary artery bypass graft was performed in 34 patients (group A), and left ventricular remodeling and coronary artery bypass graft without guided endocardial resection was performed in 25 patients (group B). Forty-three patients (group C) had coronary artery bypass graft with implantation of an automatic implantable cardioverter defibrillator (AICD). Group D (68 patients) received AICD only. After operation, based on EPS results, four patients in group A (12%) and three patients in Group B (15%) required AICD implantation. Overall survival at 6 years was 65%, 48%, 85%, and 58% in patient groups A, B, C, and D, respectively (p = not significant). During follow-up in group A patients, none died suddenly and none needed AICD. In group B, two patients required AICD 3 and 5 years later, and five patients died suddenly. The incidence of sudden death was 2.3%/patient/year and 3.5%/patient/year after AICD implantation (groups C and D). At 6 years, cardiac-event-free survival was 80% and 70% for groups A and B and 38% and 24% for groups C and D, respectively (p < 0.001). Patients receiving map-guided ablative procedures had significantly improved cardiac-event-free survival rates.
UR - http://www.scopus.com/inward/record.url?scp=0026806759&partnerID=8YFLogxK
U2 - 10.1097/00000658-199209000-00013
DO - 10.1097/00000658-199209000-00013
M3 - Article
C2 - 1417183
AN - SCOPUS:0026806759
SN - 0003-4932
VL - 216
SP - 333
EP - 343
JO - Annals of Surgery
JF - Annals of Surgery
IS - 3
ER -